Inmed Pharmaceuticals INC. (INM) — S-1 Filings
All S-1 filings from Inmed Pharmaceuticals INC.. Browse 2 IPO Filing reports with AI-powered summaries and risk analysis.
S-1 Filings (2)
-
InMed Files S-1 for Continuous Offering, Signaling Capital Raise
— Jul 9, 2025 Risk: high
InMed Pharmaceuticals Inc. (INM) filed an S-1 registration statement on July 9, 2025, for a delayed or continuous offering of securities under Rule 415. The com -
InMed Pharmaceuticals Files S-1 for Potential Offering
— Dec 23, 2024 Risk: medium
InMed Pharmaceuticals Inc. filed an S-1 registration statement on December 23, 2024, indicating plans to offer securities. The company, incorporated in British
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX